SCNI - Total Utang marang Modal BiondVax Pharmaceuticals

Logo perusahaan publik Scinai Immunotherapeutics (SCNI)

The available price action vector on GURU.Markets shows that the total debt-to-equity ratio for Scinai Immunotherapeutics (SCNI) is 0.30. Scinai Immunotherapeutics develops inhaled biologics to combat viral infections. Patent protection shields the business from price wars, although success remains dependent on regulatory approval. The executive team aims to validate the platform's efficacy through strategic alliances with industry behemoths.

SCNI: Total Utang marang Modal Scinai Immunotherapeutics Ltd. 21.02.2024 - 01.11.2026
Barang utama BiondVax Pharmaceuticals

The total debt-to-equity ratio measures the proportion of borrowed funds within the financing structure, determining the business's level of dependence on external creditors and its overall financial stability. By analyzing the trend of the total debt-to-equity ratio, an investor assesses the ability of Scinai Immunotherapeutics (SCNI) to fund the development of the NanoAb platform and scale antibody production without a critical increase in debt load during the clinical trial period.

Analisis pesaing Scinai Immunotherapeutics

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Koefisien Total Utang marang Modal Savara Pharma SVRA|RIGL: Total Utang marang Modal|Rasio Total Utang marang Ekuitas anaptysbio.com|ATXS (Astria Therapeutics, Inc.) - Total Utang marang Modal|enGene Holdings Inc (ENGN) - Koefisien Total Utang marang Modal|Utang marang Ekuitas RAPT Therapeutics, Inc. (RAPT)|aerovatetx.com - Rasio Utang marang Ekuitas|Total Utang marang Modal ACRS (Aclaris Therapeutics)|Total Utang marang Modal kyvernatx.com KYTX|Tiziana Life Sciences Ltd - Total Utang marang Modal|Koefisien Total Utang marang Modal Cabaletta Bio Inc. CABA|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|Theratechnologies, Inc - Rasio Kabeh Utang marang Dana Pribadi|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|eledon.com (ELDN) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Agenus Inc. (AGEN)|Rasio Total Utang marang Ekuitas Climb Bio Inc. CLYM|Utang marang Ekuitas Zura Bio Limited ZURA|ATYR - Rasio Total Utang marang Ekuitas|ADAG: Rasio Total Utang marang Ekuitas|IMA - Total Utang marang Modal|shattucklabs.com (STTK) - Utang marang Ekuitas|Rasio Utang marang Ekuitas EQ|Utang marang Ekuitas Connect Biopharma Holdings|Utang marang Modal Immunic Inc IMUX|Rasio Total Utang marang Ekuitas ATRA (Atara Biotherapeutics)|Utang Agregat marang Modal IFRX|Total Utang marang Modal XFOR (X4 Pharmaceuticals, Inc.)|Rasio Kabeh Utang marang Dana Pribadi ACET|Celularity Corp - Total Utang marang Modal|Utang marang Modal INmune Bio Corporation|Barinthus Biotherapeutics (BRNS) - Utang marang Ekuitas|kezarlifesciences.com - Rasio Kabeh Utang marang Dana Pribadi|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Total Utang marang Modal Akari Therapeutics PLC|Utang marang Ekuitas Enlivex Therapeutics (ENLV)|QTTB: Utang Agregat marang Ekuitas|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|edesabiotech.com (EDSA) - Utang marang Modal|IBIO: Rasio Total Utang marang Ekuitas|CARM - Total Utang marang Modal|XTLB (XTL Biopharmaceuticals, Ltd.) - Rasio Total Utang marang Ekuitas|BOLT: Utang Agregat marang Modal|HCWB (HCW Biologics, Inc.) - Total Utang marang Modal|Aptevo (APVO) - Koefisien Total Utang marang Modal|Total Utang marang Modal AIM|Rasio Total Utang marang Ekuitas aditxt.com ADTX|Utang marang Ekuitas GRI Bio Corp GRI|Koefisien Total Utang marang Modal XORTX Corp (XRTX)|HIND - Utang marang Ekuitas|Koefisien Total Utang marang Modal revbiosciences.com REVB|INDP: Total Utang marang Modal|Rasio Total Utang marang Ekuitas CalciMedica|Utang marang Ekuitas Affimed NV|Rasio Utang marang Ekuitas ALLK (Allakos Therapeutics)|Total Utang marang Modal HOOK|Koefisien Total Utang marang Modal igmbio.com|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|OCEA (Ocean Biomedical Inc) - Utang Agregat marang Ekuitas|TC BioPharm (Holdings) PLC - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi THRD (Third Harmonic Bio Inc)